Hard nut to crack: new trial brings new hope for children with peanut allergies

Aimmune Therapeutics aims take what is a known treatment for peanut allergy – oral immunotherapy – and make it into a licensed pharmaceutical product capable of protecting patients from the life-threatening reactions they experience when exposed to peanuts. Credit: Courtesy of U.S. Department of Agriculture.